Stay updated with breaking news from Binding Site. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Once acquired, the Birmingham, UK-based blood cancer and immune disease diagnostics company will become part of Thermo Fisher's specialty diagnostics segment.
Once acquired, the Birmingham, UK-based blood cancer and immune disease diagnostics company will become part of Thermo Fisher's specialty diagnostics segment.
Thermo Fisher Scientific (NYSE:TMO) announced today that it entered into a definitive agreement to acquire The Binding Site Group.
/PRNewswire/ -- As this year's Myeloma Action Month came to a close, the International Myeloma Foundation (IMF) was unwavering in achieving its goals. By...
The impaired transplacental passage of IgG from mothers living with HIV to their infants could be one of the causes of the high vulnerability to infections of HIV-exposed uninfected (HEU) infants, but controversial results have been obtained in different settings. The aim of this study was to assess in 6-week old HEU and HIV-unexposed, uninfected (HUU) Malawian infants the total IgG levels, the subclasses profile and the concentrations of global anti-pneumococcal capsular polysaccharide (anti-PCP) IgG and IgG2. Dried blood spots were collected from 80 infants (40 HEU, 40 HUU) and antibodies co...